nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylpropion—Etomidate—CYP19A1—esophageal cancer	0.0515	0.23	CrCbGaD
Diethylpropion—Tiaprofenic acid—PTGS1—esophageal cancer	0.05	0.224	CrCbGaD
Diethylpropion—Selegiline—CYP2A6—esophageal cancer	0.0303	0.136	CrCbGaD
Diethylpropion—Tiaprofenic acid—PTGS2—esophageal cancer	0.0286	0.128	CrCbGaD
Diethylpropion—Levomilnacipran—ABCB1—esophageal cancer	0.0265	0.119	CrCbGaD
Diethylpropion—Amphetamine—CYP2A6—esophageal cancer	0.0252	0.113	CrCbGaD
Diethylpropion—Bone marrow depression—Capecitabine—esophageal cancer	0.0204	0.0312	CcSEcCtD
Diethylpropion—Polyuria—Cisplatin—esophageal cancer	0.0154	0.0236	CcSEcCtD
Diethylpropion—Bone marrow depression—Methotrexate—esophageal cancer	0.0152	0.0232	CcSEcCtD
Diethylpropion—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.0142	0.116	CbGpPWpGaD
Diethylpropion—Cerebrovascular accident—Cisplatin—esophageal cancer	0.0138	0.0212	CcSEcCtD
Diethylpropion—Blood pressure increased—Capecitabine—esophageal cancer	0.0138	0.0211	CcSEcCtD
Diethylpropion—Ecchymosis—Capecitabine—esophageal cancer	0.0125	0.019	CcSEcCtD
Diethylpropion—Urine output increased—Capecitabine—esophageal cancer	0.0125	0.019	CcSEcCtD
Diethylpropion—Sweating increased—Cisplatin—esophageal cancer	0.0114	0.0175	CcSEcCtD
Diethylpropion—Polyuria—Capecitabine—esophageal cancer	0.0114	0.0174	CcSEcCtD
Diethylpropion—Selegiline—ABCB1—esophageal cancer	0.0113	0.0505	CrCbGaD
Diethylpropion—Abdominal discomfort—Cisplatin—esophageal cancer	0.0112	0.0172	CcSEcCtD
Diethylpropion—Pancytopenia—Cisplatin—esophageal cancer	0.0111	0.017	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Capecitabine—esophageal cancer	0.0102	0.0156	CcSEcCtD
Diethylpropion—Ecchymosis—Methotrexate—esophageal cancer	0.00927	0.0142	CcSEcCtD
Diethylpropion—Urine output increased—Methotrexate—esophageal cancer	0.00927	0.0142	CcSEcCtD
Diethylpropion—Gynaecomastia—Methotrexate—esophageal cancer	0.00917	0.014	CcSEcCtD
Diethylpropion—Polyuria—Methotrexate—esophageal cancer	0.00848	0.013	CcSEcCtD
Diethylpropion—Sweating increased—Capecitabine—esophageal cancer	0.00842	0.0129	CcSEcCtD
Diethylpropion—Arrhythmia—Cisplatin—esophageal cancer	0.00838	0.0128	CcSEcCtD
Diethylpropion—SLC6A3—Alpha-synuclein signaling—UCHL1—esophageal cancer	0.00836	0.0682	CbGpPWpGaD
Diethylpropion—Alopecia—Cisplatin—esophageal cancer	0.00829	0.0127	CcSEcCtD
Diethylpropion—Abdominal discomfort—Capecitabine—esophageal cancer	0.00828	0.0127	CcSEcCtD
Diethylpropion—Pancytopenia—Capecitabine—esophageal cancer	0.00821	0.0125	CcSEcCtD
Diethylpropion—Erythema—Cisplatin—esophageal cancer	0.00817	0.0125	CcSEcCtD
Diethylpropion—Dysuria—Capecitabine—esophageal cancer	0.00808	0.0124	CcSEcCtD
Diethylpropion—SLC6A3—Alpha-synuclein signaling—FKBP1A—esophageal cancer	0.00796	0.0649	CbGpPWpGaD
Diethylpropion—Vision blurred—Cisplatin—esophageal cancer	0.0077	0.0118	CcSEcCtD
Diethylpropion—Tremor—Cisplatin—esophageal cancer	0.00765	0.0117	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Methotrexate—esophageal cancer	0.0076	0.0116	CcSEcCtD
Diethylpropion—Ill-defined disorder—Cisplatin—esophageal cancer	0.00758	0.0116	CcSEcCtD
Diethylpropion—Malaise—Cisplatin—esophageal cancer	0.00737	0.0113	CcSEcCtD
Diethylpropion—Leukopenia—Cisplatin—esophageal cancer	0.00731	0.0112	CcSEcCtD
Diethylpropion—Agranulocytosis—Capecitabine—esophageal cancer	0.00719	0.011	CcSEcCtD
Diethylpropion—SLC6A3—Parkinsons Disease Pathway—UCHL1—esophageal cancer	0.00711	0.058	CbGpPWpGaD
Diethylpropion—Convulsion—Cisplatin—esophageal cancer	0.00708	0.0108	CcSEcCtD
Diethylpropion—Myalgia—Cisplatin—esophageal cancer	0.00695	0.0106	CcSEcCtD
Diethylpropion—Anxiety—Cisplatin—esophageal cancer	0.00693	0.0106	CcSEcCtD
Diethylpropion—Discomfort—Cisplatin—esophageal cancer	0.00687	0.0105	CcSEcCtD
Diethylpropion—Tachycardia—Cisplatin—esophageal cancer	0.00651	0.00995	CcSEcCtD
Diethylpropion—Hyperhidrosis—Cisplatin—esophageal cancer	0.00644	0.00985	CcSEcCtD
Diethylpropion—Arrhythmia—Capecitabine—esophageal cancer	0.00618	0.00945	CcSEcCtD
Diethylpropion—Abdominal discomfort—Methotrexate—esophageal cancer	0.00617	0.00943	CcSEcCtD
Diethylpropion—Alopecia—Capecitabine—esophageal cancer	0.00611	0.00934	CcSEcCtD
Diethylpropion—Pancytopenia—Methotrexate—esophageal cancer	0.00611	0.00934	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00607	0.00928	CcSEcCtD
Diethylpropion—Erythema—Capecitabine—esophageal cancer	0.00602	0.0092	CcSEcCtD
Diethylpropion—Dysuria—Methotrexate—esophageal cancer	0.00602	0.0092	CcSEcCtD
Diethylpropion—Dyspnoea—Cisplatin—esophageal cancer	0.00594	0.00909	CcSEcCtD
Diethylpropion—Erectile dysfunction—Methotrexate—esophageal cancer	0.00592	0.00906	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00576	0.0088	CcSEcCtD
Diethylpropion—Drowsiness—Methotrexate—esophageal cancer	0.00574	0.00877	CcSEcCtD
Diethylpropion—Vision blurred—Capecitabine—esophageal cancer	0.00567	0.00867	CcSEcCtD
Diethylpropion—Tremor—Capecitabine—esophageal cancer	0.00564	0.00862	CcSEcCtD
Diethylpropion—Ill-defined disorder—Capecitabine—esophageal cancer	0.00559	0.00854	CcSEcCtD
Diethylpropion—Feeling abnormal—Cisplatin—esophageal cancer	0.00549	0.0084	CcSEcCtD
Diethylpropion—Malaise—Capecitabine—esophageal cancer	0.00543	0.0083	CcSEcCtD
Diethylpropion—SLC6A3—Dopaminergic Neurogenesis—SOX2—esophageal cancer	0.00539	0.044	CbGpPWpGaD
Diethylpropion—Leukopenia—Capecitabine—esophageal cancer	0.00539	0.00824	CcSEcCtD
Diethylpropion—Agranulocytosis—Methotrexate—esophageal cancer	0.00535	0.00818	CcSEcCtD
Diethylpropion—Palpitations—Capecitabine—esophageal cancer	0.00532	0.00813	CcSEcCtD
Diethylpropion—Chest pain—Capecitabine—esophageal cancer	0.00513	0.00784	CcSEcCtD
Diethylpropion—Myalgia—Capecitabine—esophageal cancer	0.00513	0.00784	CcSEcCtD
Diethylpropion—Anxiety—Capecitabine—esophageal cancer	0.00511	0.00781	CcSEcCtD
Diethylpropion—Discomfort—Capecitabine—esophageal cancer	0.00506	0.00774	CcSEcCtD
Diethylpropion—Dry mouth—Capecitabine—esophageal cancer	0.00501	0.00766	CcSEcCtD
Diethylpropion—Tachycardia—Capecitabine—esophageal cancer	0.0048	0.00733	CcSEcCtD
Diethylpropion—Hyperhidrosis—Capecitabine—esophageal cancer	0.00475	0.00726	CcSEcCtD
Diethylpropion—Diarrhoea—Cisplatin—esophageal cancer	0.00456	0.00697	CcSEcCtD
Diethylpropion—Alopecia—Methotrexate—esophageal cancer	0.00455	0.00696	CcSEcCtD
Diethylpropion—Erythema—Methotrexate—esophageal cancer	0.00448	0.00685	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00448	0.00684	CcSEcCtD
Diethylpropion—Insomnia—Capecitabine—esophageal cancer	0.00444	0.00679	CcSEcCtD
Diethylpropion—Dyspnoea—Capecitabine—esophageal cancer	0.00438	0.0067	CcSEcCtD
Diethylpropion—Dyspepsia—Capecitabine—esophageal cancer	0.00433	0.00661	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00424	0.00649	CcSEcCtD
Diethylpropion—Vomiting—Cisplatin—esophageal cancer	0.00424	0.00648	CcSEcCtD
Diethylpropion—Vision blurred—Methotrexate—esophageal cancer	0.00422	0.00646	CcSEcCtD
Diethylpropion—Rash—Cisplatin—esophageal cancer	0.0042	0.00643	CcSEcCtD
Diethylpropion—Constipation—Capecitabine—esophageal cancer	0.0042	0.00642	CcSEcCtD
Diethylpropion—Dermatitis—Cisplatin—esophageal cancer	0.0042	0.00642	CcSEcCtD
Diethylpropion—Ill-defined disorder—Methotrexate—esophageal cancer	0.00416	0.00636	CcSEcCtD
Diethylpropion—Feeling abnormal—Capecitabine—esophageal cancer	0.00405	0.00619	CcSEcCtD
Diethylpropion—Malaise—Methotrexate—esophageal cancer	0.00404	0.00618	CcSEcCtD
Diethylpropion—Leukopenia—Methotrexate—esophageal cancer	0.00401	0.00613	CcSEcCtD
Diethylpropion—Nausea—Cisplatin—esophageal cancer	0.00396	0.00605	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—ALDH3A1—esophageal cancer	0.00394	0.0322	CbGpPWpGaD
Diethylpropion—Urticaria—Capecitabine—esophageal cancer	0.0039	0.00597	CcSEcCtD
Diethylpropion—Convulsion—Methotrexate—esophageal cancer	0.00388	0.00594	CcSEcCtD
Diethylpropion—Chest pain—Methotrexate—esophageal cancer	0.00382	0.00583	CcSEcCtD
Diethylpropion—Myalgia—Methotrexate—esophageal cancer	0.00382	0.00583	CcSEcCtD
Diethylpropion—Discomfort—Methotrexate—esophageal cancer	0.00377	0.00576	CcSEcCtD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00369	0.0301	CbGpPWpGaD
Diethylpropion—Hyperhidrosis—Methotrexate—esophageal cancer	0.00354	0.00541	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—BLVRB—esophageal cancer	0.00351	0.0287	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—ALDH3A1—esophageal cancer	0.00349	0.0285	CbGpPWpGaD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00338	0.0276	CbGpPWpGaD
Diethylpropion—Diarrhoea—Capecitabine—esophageal cancer	0.00336	0.00514	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00333	0.00509	CcSEcCtD
Diethylpropion—Insomnia—Methotrexate—esophageal cancer	0.00331	0.00506	CcSEcCtD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00327	0.0267	CbGpPWpGaD
Diethylpropion—Dyspnoea—Methotrexate—esophageal cancer	0.00326	0.00499	CcSEcCtD
Diethylpropion—Somnolence—Methotrexate—esophageal cancer	0.00325	0.00497	CcSEcCtD
Diethylpropion—Dizziness—Capecitabine—esophageal cancer	0.00325	0.00497	CcSEcCtD
Diethylpropion—Dyspepsia—Methotrexate—esophageal cancer	0.00322	0.00492	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00316	0.00483	CcSEcCtD
Diethylpropion—Vomiting—Capecitabine—esophageal cancer	0.00312	0.00478	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—BLVRB—esophageal cancer	0.00311	0.0254	CbGpPWpGaD
Diethylpropion—Rash—Capecitabine—esophageal cancer	0.0031	0.00474	CcSEcCtD
Diethylpropion—Dermatitis—Capecitabine—esophageal cancer	0.0031	0.00473	CcSEcCtD
Diethylpropion—Headache—Capecitabine—esophageal cancer	0.00308	0.00471	CcSEcCtD
Diethylpropion—Feeling abnormal—Methotrexate—esophageal cancer	0.00301	0.00461	CcSEcCtD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00299	0.0244	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—PRDX1—esophageal cancer	0.00299	0.0244	CbGpPWpGaD
Diethylpropion—Nausea—Capecitabine—esophageal cancer	0.00292	0.00446	CcSEcCtD
Diethylpropion—Urticaria—Methotrexate—esophageal cancer	0.00291	0.00444	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—SLC39A6—esophageal cancer	0.00266	0.0217	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—PRDX1—esophageal cancer	0.00265	0.0216	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—ADH7—esophageal cancer	0.00254	0.0207	CbGpPWpGaD
Diethylpropion—Diarrhoea—Methotrexate—esophageal cancer	0.0025	0.00383	CcSEcCtD
Diethylpropion—Dizziness—Methotrexate—esophageal cancer	0.00242	0.0037	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—SLC39A6—esophageal cancer	0.00236	0.0193	CbGpPWpGaD
Diethylpropion—Vomiting—Methotrexate—esophageal cancer	0.00233	0.00356	CcSEcCtD
Diethylpropion—Rash—Methotrexate—esophageal cancer	0.00231	0.00353	CcSEcCtD
Diethylpropion—Dermatitis—Methotrexate—esophageal cancer	0.0023	0.00352	CcSEcCtD
Diethylpropion—Headache—Methotrexate—esophageal cancer	0.00229	0.0035	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—ADH7—esophageal cancer	0.00225	0.0184	CbGpPWpGaD
Diethylpropion—Nausea—Methotrexate—esophageal cancer	0.00217	0.00332	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—ABCC2—esophageal cancer	0.00185	0.0151	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—NFE2L2—esophageal cancer	0.00172	0.014	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00168	0.0137	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—ABCC2—esophageal cancer	0.00164	0.0133	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00154	0.0125	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—NFE2L2—esophageal cancer	0.00152	0.0124	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00149	0.0121	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—CYP2A6—esophageal cancer	0.00148	0.012	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00136	0.0111	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—CYP2A6—esophageal cancer	0.00131	0.0107	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00115	0.00941	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00108	0.00882	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—TGFBR2—esophageal cancer	0.00103	0.00844	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—HMOX1—esophageal cancer	0.00102	0.00833	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000957	0.00781	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—TGFBR2—esophageal cancer	0.000917	0.00748	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—HMOX1—esophageal cancer	0.000904	0.00738	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.0009	0.00734	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—GNG7—esophageal cancer	0.000884	0.00721	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000853	0.00696	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000848	0.00692	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—ALDH2—esophageal cancer	0.000828	0.00676	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000814	0.00664	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000797	0.0065	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00078	0.00637	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00078	0.00637	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000756	0.00617	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000721	0.00588	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000691	0.00564	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000691	0.00564	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000591	0.00482	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000537	0.00438	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000524	0.00427	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000475	0.00388	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000327	0.00267	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000314	0.00256	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00029	0.00236	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000278	0.00227	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00021	0.00171	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000186	0.00152	CbGpPWpGaD
